JAZF1: A Zinc Finger Protein 1 Target for Drug Development and Cancer Research

Target Name: JAZF1

NCBI ID: G221895

JAZF1

JAZF1: A Zinc Finger Protein 1 Target for Drug Development and Cancer Research

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in gene regulation and have been implicated in various diseases, including cancer. Zinc finger proteins are composed of a unique nucleotide-binding domain and can interact with various protein partners to regulate gene expression. One of the most promising findings in the field of ZFPs is the identification of JAZF1, a zinc finger protein that has been shown to participate in various cellular processes and has been implicated in various diseases, including cancer. In this article, we will explore the JAZF1 protein, its potential as a drug target, and its implications for cancer research.

Structure and Function

JAZF1 is a 21-kDa protein that contains a nucleotide-binding domain and a C-terminal ZFP. The nucleotide-binding domain is composed of a parallel beta-sheet and a single alpha-helicase domain, which are responsible for the binding of nucleotides. The C-terminal region of JAZF1 contains a ZFP that is composed of a variable number of exons, which results in a variable ZFP length.

JAZF1 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and cell-cell adhesion. JAZF1 has also been shown to be involved in the regulation of gene expression, including the regulation of cell cycle progression and the establishment of stem cell properties.

JAZF1 has also been implicated in the development and progression of various cancers, including breast, ovarian, and prostate cancers. JAZF1 has been shown to be overexpressed in various cancer tissues and has been associated with cancer-related traits, such as poor prognosis and the development of drug resistance.

Drug Target Potential

JAZF1 has the potential to be a drug target due to its unique structure and function. One of the most promising strategies for targeting JAZF1 is the use of small molecules that can modulate its activity.

One of the most promising small molecules is a fragment of the zinc finger gene, ZNF2, which has been shown to interact with JAZF1 and can inhibit its activity. ZNF2 has also been shown to be a potential drug candidate for the treatment of various cancers, including breast, ovarian, and prostate cancers.

Another small molecule that has been shown to interact with JAZF1 is 2-methylpropionitrile (2-MP), which has been shown to inhibit the activity of JAZF1 and induce cell apoptosis. 2-MP has been shown to be a potential drug candidate for the treatment of various cancers, including breast, ovarian, and prostate cancers.

In conclusion, JAZF1 is a zinc finger protein that has been shown to play a role in various cellular processes and has been implicated in various diseases, including cancer. The unique structure and function of JAZF1 make it an attractive target for drug development and cancer research. The use of small molecules, such as ZNF2 and 2-MP, have the potential to modulate JAZF1 activity and lead to the development of new treatments for various cancers.

Conclusion

JAZF1 is a zinc finger protein that has been shown to play a role in various cellular processes and has been implicated in various diseases, including cancer. Its unique structure and function make it an attractive target for drug development and cancer research. The use of small molecules, such as ZNF2 and 2-MP, have the potential to modulate JAZF1 activity and lead to the development of new treatments for various cancers. Further research is needed to fully understand the role of JAZF1 in cancer and to develop effective treatments.

Protein Name: JAZF Zinc Finger 1

Functions: Acts as a transcriptional corepressor of orphan nuclear receptor NR2C2 (PubMed:15302918). Inhibits expression of the gluconeogenesis enzyme PCK2 through inhibition of NR2C2 activity (By similarity). Also involved in transcriptional activation of NAMPT by promoting expression of PPARA and PPARD (By similarity). Plays a role in lipid metabolism by suppressing lipogenesis, increasing lipolysis and decreasing lipid accumulation in adipose tissue (By similarity). Plays a role in glucose homeostasis by improving glucose metabolism and insulin sensitivity (By similarity)

The "JAZF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about JAZF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets